ANNUAL REPORT HOME ABOUT GENZYME SITEMAP LEGAL DISCLAIMER 
2006 Annual Report
Genzyme Logo
TABLE OF CONTENTS
Financial Highlights
Letter to Shareholders
Our Passion
Our Presence
Our Portfolio
Our Engine is Innovation
Renal Disease
Genetic Diseases
Orthopaedics/Biosurgical Specialties
Oncology/Endocrinology
Transplant/Immune Diseases
Genetics/Diagnostics
Our Pipeline
Our Commitment
Our Social Responsibility
Our Employees
Brandon Camden - Treated with Clolar therapy

Twelve-year-old Brandon Camden was diagnosed with acute lymphoblastic leukemia in 2001. After experiencing three relapses of his leukemia, he was treated with Clolar therapy and, once the cancer was in remission, received a cord-blood transplant in May 2006. Brandon kept up with his studies even when he was not able to attend school, and he was very excited to return to his fifth-grade classroom this year, where math is currently his favorite subject.